Effect of warfarin use on bleeding complications: bronchoscopy with transbronchial biopsies for peripheral lesion

Effect of warfarin use on bleeding complications: bronchoscopy with transbronchial biopsies for peripheral lesion - Effect of warfarin use on bleeding complications: bronchoscopy with transbronchial biopsies for peripheral lesion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011011

Enrollment

120

Registered

2013-06-20

Start date

2013-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects of bronchoscopy during warfarin therapy

Interventions

during warfarin therapy Control

not use antithrombogenic drug

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. subjects of a bronchoscopy 2. cases written informed consent was obtained 3. cases of suspected to malignant disease for peripheral lesion 4. satisfy following items Plate >= 50,000/mm3 ALT <= 150 IU/L AST <= 150 IU/L T.Bil <= 1.5 mg/dL Cr <= 1.5 mg/dL 1.5<INR<3.0

Exclusion criteria

Exclusion criteria: 1.medical history of bleeding tendency or hemoptysis 2.concurrent use of steroid therapy 3.cases of needing high invasive procedure (cauterization or stent) 4.cases of emergency examination 5.patients with active concomitant pregnancy 6.patients with serious drug allergic reactions. 7.patients who were deemed inappropriate to the subject of this study by attending physician

Design outcomes

Primary

Measure	Time frame
1. amount of bleeding during bronchoscopy 2. complications	—

Countries

Japan

Contacts

Public Contacttakamasa hotta

Shimane University Faculty of Medicine Department of Internal Medicine, Division of Medical Oncology and Respiratory Medicine

hotta.takamasa@gmail.com0853-23-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026